The mean serum levels of IL-23 and -27 were elevated during the acute phase of GBS when compared to the central nervous system demyelinating diseases group, OND group, and HC group (p < 0.001; p < 0.001; Fig. 1a,c). This evidence concerns the gene IL23A and demyelinating disease.